Gastric cancer in Spain: evaluating productivity loss and economic impact
Introduction In 2018, gastric cancer (GC) was estimated to account for over 1.03 million new cases globally, making it one of the most frequently diagnosed malignancies. In Spain, about 6,913 new cases were diagnosed in 2022. GC is an aggressive cancer originating in the stomach and ranks fifth in c...
| Authors: | , , |
|---|---|
| Format: | article |
| Status: | Versión aceptada para publicación |
| Publication Date: | 2024 |
| Country: | España |
| Institution: | Universidad de Barcelona |
| Repository: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/221806 |
| Online Access: | https://hdl.handle.net/2445/221806 |
| Access Level: | Open access |
| Keyword: | Càncer d'estómac Avaluació de l'assistència mèdica Anàlisi d'impacte econòmic Stomach cancer Medical care evaluation Economic impact analysis |
| Summary: | Introduction In 2018, gastric cancer (GC) was estimated to account for over 1.03 million new cases globally, making it one of the most frequently diagnosed malignancies. In Spain, about 6,913 new cases were diagnosed in 2022. GC is an aggressive cancer originating in the stomach and ranks fifth in cancer incidence and third in cancer-related deaths worldwide. Despite treatment, only 25% of patients survive more than 5 years after diagnosis. |
|---|